Vol. 3 No. 3

Review Articles

Study on Traditional Chinese Medicine Syndrome Types in NPC

Published 2026-05-31

  • Yao Wu
    • ,
  • Lin Chen
    • ,
  • Faqing Tang

Yao Wu
First Affiliated Hospital of Hunan University of Traditional Chinese Medicine image/svg+xml

Lin Chen
First Affiliated Hospital of Hunan University of Traditional Chinese Medicine image/svg+xml

Faqing Tang
Hunan Cancer Hospital image/svg+xml

Abstract

As one of head and neck tumors, nasopharyngeal carcinoma (NPC) occurs most frequently in the south of China, especially in Hunan, Guangzhou and other places, causing serious harm to people's life and health. NPC patient is mainly treated with radiotherapy in clinic, but most of them have serious side effects. At present, traditional Chinese medicine (TCM) combined with chemoradiotherapy in the treatment of NPC patient has been focused on by Chinese and Western clinicians. Although TCM syndrome differentiation has significant advantages in the treatment of nasopharyngeal cancer, the relevant syndrome type standards for TCM syndrome differentiation guidance are still not unified. Therefore, this paper summarized the clinical experience, clinical data analysis and experimental research of TCM scholars in recent years, discussed the role and influence of TCM syndrome differentiation on the treatment of NPC. It provides some guidance for the standardization of TCM syndrome differentiation of NPC patients.

Keywords

Nasopharyngeal carcinoma, TCM syndrome type, Syndrome differentiation and treatment, Radiation therapy, Constitution theory

PDF

References

  1. Tang LL, Chen YP, Chen CB, et al. The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of NPC [J]. Cancer Commun (London), 2021,41(11):1195–227. DOI: https://doi.org/10.1002/cac2.12218.
  2. Guan S, Wei J, Huang L, et al. Chemotherapy and chemo-resistance in NPC [J]. Eur J Med Chem, 2020, 207: 112758. DOI: https://doi.org/10.1016/j.ejmech.2020.112758.
  3. Xiang Y, Guo Z, Zhu P, et al. Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science [J]. Cancer Med, 2019, 8(5): 1958-75. DOI: https://doi.org/10.1002/cam4.2108.
  4. Yixin Cui, Gege Chen, Haiming Wang. Discussion on the Integrated Treatment Model of Traditional Chinese Medicine for Malignant Tumors Combining Disease Differentiation and Syndrome Differentiation [J]. Modern Oncology Medicine, 2022,30(13):2483-2486.
  5. Shigong Chen. Critical Edition and Commentary on Xu's Surgical Treatise [M]. Beijing: Xueyuan Publishing House, 1997.
  6. Bingjun Gao. Collection of Insights on Ulcer Diseases [M]. Nanjing: Jiangsu Science and Technology Press, 1983.
  7. Qian Wu. Medical Canon: The Golden Mirror [M]. Beijing: People's Medical Publishing House, 2nd ed., 1985.
  8. Lu Zhang. Zhang's Medical Compendium [M]. Shanghai: Shanghai Scientific and Technical Publishing House, 1963.
  9. Peizhi Ma. Surgical Medical Cases of Ma Peizhi. See: Wang Xinhua (Ed.). Selected Medical Cases from Chinese Medicine Through the Ages [M]. Nanjing: Jiangsu Science and Technology Press, 1993.
  10. Xiaojun Zhou, Daofa Tian. Research on Ancient Literature on NPC [J]. Chinese Journal of Medical History, 2001,31(2):115-118.
  11. Tong Zhou, Zi 'ang Yao, Shuaihang Hu, et al. Exploration of the medication patterns in Professor Hou Wei's TCM maintenance therapy for NPC based on the Traditional Chinese Medicine Inheritance Assistance Platform [J]. Journal of Traditional Chinese Medicine, 2021,27(6):5.
  12. Xiaojun Zhou, Qian Lan. Clinical presentation and epidemiological characteristics of NPC [J]. Chinese Journal of Traditional Chinese Medicine, 2021,36(8):4587-90.
  13. Rui Sun, Dongfang Li. Clinical Experience of Li Yueheng in Treating NPC [J]. Journal of Traditional Chinese Medicine, 2023,29(2):5.
  14. Wenyá She, Daofa Tian, Xianwen Wang. Summary of clinical experience in treating NPC based on the "Qi deficiency and toxin accumulation" theory by Professor Tian Daofa [J]. China Journal of Integrated Traditional Chinese and Western Medicine in Otorhinolaryngology, 2023,31(1):69-74.
  15. Chinese Association of Traditional Chinese Medicine. Guidelines for Tumor Diagnosis and Treatment in Traditional Chinese Medicine [M]. Beijing: China Traditional Chinese Medicine Press, 2008.
  16. Daihan Zhou. Traditional Chinese Medicine Oncology [M]. Beijing: China Traditional Chinese Medicine Press, 2011.
  17. Jingyi Xie, Zhanhua Liu. A Preliminary Study on Professor Zhou Daihan's Experience in Treating NPC [J]. Journal of Traditional Chinese Oncology, 2021,3(4):5.
  18. Daofa Tian, Yunying Li. Integrated Traditional Chinese and Western Medicine in Otorhinolaryngology [M]. Beijing: China Traditional Chinese Medicine Press, 2016.
  19. Simons MJ. NPC as a paradigm of cancer genetics [J]. Chin J Cancer, 2011, 30(2): 79-84. DOI: https://doi.org/10.5732/cjc.010.10609.
  20. Chang ET, Ye W, Zeng YX, et al. The Evolving Epidemiology of NPC [J]. Cancer Epidemiol Biomarkers Prev, 2021, 30(6): 1035-47. DOI: https://doi.org/10.1158/1055-9965.EPI-20-1702.
  21. Xiaojun Zhou, Daofa Tian. Research Progress on Pathological Characteristics of High-Risk Populations for NPC [J]. Guangxi Medical Journal, 2002,24(5):4.
  22. Daofa Tian, Yingchun He. Research on the pathogenesis theory of "Qi deficiency and toxin invasion" in nasopharyngeal precancerous lesions [J]. Journal of Traditional Chinese Medicine Otorhinolaryngology Research, 2008, (1):6.
  23. Xiaojun Zhou, Daofa Tian, Shizhen Wang, et al. Genomic stability and repair gene expression in members of a high-risk family for NPC with qi-deficient constitution [J]. Traditional Chinese Medicine Information, 2009,26(5):4.
  24. Xiaojun Zhou, Daofa. Tian Family-based constitutional survey study on NPC [J]. China Journal of Basic Medical Sciences of Traditional Chinese Medicine, 2002,8(11):4.
  25. Xiaojun Zhou, Daofa Tian. Investigation on the Physical Constitution of High-Risk Populations for NPC [J]. China Journal of Basic Medical Sciences of Traditional Chinese Medicine, 2003,9(8):4.
  26. Xiaojun Zhou, Shizhen Wang, Yan Ruan, et al. Investigation of Traditional Chinese Medicine Constitutional Syndromes During the Progression of NPC [J]. Chinese Journal of Traditional Chinese Medicine, 2008, (4):721-3.
  27. Xiuying Qu, Lu Lu, Xianhong Li, et al. Distribution characteristics and association rule analysis of Traditional Chinese Medicine constitution types in the Lingnan region [J]. New Chinese Medicine, 2020,52(7):4.
  28. Xiaojun Zhou, Daofa Tian, Shizhen Wang. EB virus infection and the concept of "Fu Xie" in Traditional Chinese Medicine [J]. Journal of Traditional Chinese Medicine Otorhinolaryngology Research, 2007, (1):3.
  29. Xiaoling Yang, Wenyong Chen. Study on the constitutional characteristics of EBV-positive individuals and the intervention effect of Yiqi Gubiao Ointment combined with Traditional Chinese Medicine chronic disease management protocol [J]. Journal of Guangzhou University of Chinese Medicine, 2019,36(12):4.
  30. Shuhua Chen, Daofa Tian, Jiping Zhang, et al. Bidirectional gel electrophoresis analysis of histone proteins in nasopharyngeal tumor tissues from patients with different constitutional types within high-risk NPC families [J]. China Journal of Integrated Traditional and Western Medicine in Otorhinolaryngology, 2010, (1):4.
  31. Baorui Lin. Meridian Deficiency-Excess Characteristics and Qi Deficiency-Malignant Transformation microRNA Research in NPC [D]. Guangzhou University of Chinese Medicine, 2017.
  32. Yingchun He, Daofa Tian. Construction and characterization of a double-gene recombinant plasmid containing mutant p53 and LMP1 [J]. Journal of Hunan University of Chinese Medicine, 2005,25(3):3.
  33. Xihua Cheng. Research on the apoptosis signaling pathways induced by qi deficiency and toxin-induced pathogenesis in nasopharyngeal epithelial carcinogenesis of rats and their intervention [D]; Hunan University of Chinese Medicine, 2007.
  34. Wei Lu, Mianhua Wu. Professor Wu Mianhua's Treatment of NPC Damage After Radiotherapy Based on the Theory of Concurrent Deficiency of Qi and Yin [J]. Chinese Journal of Traditional Chinese Medicine, 2016,34(9):3.
  35. Yan Wu, Mianhua Wu. Analysis of Professor Wu Mianhua's Clinical Cases in the Diagnosis and Treatment of NPC [J]. Journal of Traditional Chinese Medicine, 2019, (7):3.
  36. Chunying Xu, Jing Liu. Experience in Traditional Chinese Medicine Syndrome Differentiation and Treatment for NPC [J]. Beijing Journal of Traditional Chinese Medicine, 2017,36(8):3.
  37. Lili He, Kebao Gu, Lanyu Chen, et al. A Brief Discussion on the Experience of Sun Guizhi in Diagnosing and Treating NPC [J]. Chinese Journal of Traditional Chinese Medicine, 2021,36(02):884-887.
  38. Shaochu He, Li 'e Deng, Zhike Fang, et al. Two clinical cases of He Shidong's syndrome differentiation and treatment approach for NPC after chemoradiotherapy [J]. New Chinese Medicine, 2016,48(1):3.
  39. Chongxiang Sun, Guiwei Li. Case study on treating oral dryness after radiotherapy for NPC from the perspective of spleen and stomach [J]. China Folk Therapy, 2023,31(14):88-90.
  40. Bingqian Yu, Hua an Ma. An empirical analysis of Chen Guofeng's application of traditional Chinese medicine in managing toxic side effects following radiotherapy for NPC [J]. Jiangsu Journal of Traditional Chinese Medicine, 2019,51(6):3.
  41. Guanying Qiao, Jingyu Rong, Lizhu Lin. Professor Lin Lizhu treats NPC by addressing the lungs and liver [J]. Jilin Journal of Traditional Chinese Medicine, 2014, (3):3.
  42. Jing Li, Chi Zhang, Ke Lu, et al. Data mining analysis of medication patterns in traditional Chinese medicine maintenance therapy for NPC by Lin Lizhu [J]. Journal of Guangzhou University of Chinese Medicine, 2019,36(7):7.
  43. Huang Y. Study on the Evolution Patterns of Traditional Chinese Medicine Syndrome Types in Patients with NPC Undergoing Chemoradiotherapy Based on Cluster Analysis [J]. Inner Mongolia Journal of Traditional Chinese Medicine, 2023,42(5):146-148.
  44. Fangbing Chi, Minqiu Pan, Bo Pan, et al. Experience of Pan Minqiu in treating radiation-induced oral mucositis after radiotherapy for NPC [J]. Hunan Journal of Traditional Chinese Medicine, 2019,35(4):2.
  45. Yiting Gu, Xiaoning Chen. Treatment Approaches and Methods of Traditional Chinese Medicine after Radiotherapy and Chemotherapy for NPC [J]. Chinese Journal of Traditional Medicine Information, 2019,36(5):3.
  46. Zhang H, Zeng S. Clinical observation on the correlation between TCM syndrome differentiation and TNM staging in initially diagnosed NPC patients [J]. Journal of Traditional Chinese Medicine, 2011,17(7):3.
  47. Yajun Li, Yan Zou, Peigang Ruan, et al. Correlation analysis between TCM syndrome types and UICC 2010 staging in NPC [J]. China Medical Innovation.
  48. Zhou Li, Pan Yandong, Zhu Lin, et al. Relationship between TCM syndrome types of nasopharyngeal carcinoma and its clinical stages and differentiation degree [J]. Clinical Medical Engineering, 2020,27(7):2.
  49. Chen Ping, Huang Yuanyuan, Li Tingwei, et al. Relationship between serum CRP levels and traditional Chinese medicine syndrome differentiation in patients initially diagnosed with nasopharyngeal carcinoma [J]. Practical Integrated Traditional Chinese and Western Medicine Clinical Practice, 2017,17(6):3.
  50. Gao Zhuowei, Zhou Yingchun, Guo Jinhui, et al. Study on Traditional Chinese Medicine Syndromes and TGF-β1 in Initial Diagnosis Patients with Nasopharyngeal Carcinoma [J]. Journal of Practical Internal Medicine of Traditional Chinese Medicine, 2015, v. 29(8):1–2.
  51. Li Xiang, Yan Wenjie, Xia Jiyan. Preliminary study on the role of EGFR in clinical staging of nasopharyngeal carcinoma and its relationship with TCM syndrome types [J]. China Journal of Otorhinolaryngology: Integrated Traditional Chinese and Western Medicine, 2012,20(6):6.
  52. Yan Wenjie, Cao Huanguang, Wei Mingzhuang, et al. Correlation analysis of EGFR expression with clinical staging and prognosis in different TCM syndrome types of nasopharyngeal carcinoma [J]. Journal of Guangdong University of Pharmaceutical Sciences, 2018,34(04):508–512.
  53. Li Yuqi, Pan Yunyun, Chen Size, et al. Study on the correlation between TCM syndrome patterns and VEGF levels before and after chemoradiotherapy in intermediate-to advanced nasopharyngeal carcinoma [J]. Clinical Medical Engineering, 2018,25(9):2.
  54. Tang Qiu, Guo Yong, Hu Qiaoying. Study on the radiosensitizing effect of Zilongjin on transplanted nasopharyngeal carcinoma tumors in nude mice [J]. China Oncology, 2013,22(009):737-42.
  55. Lou Yi. Jia Yingjie's experience in treating post-radiotherapy oral taste loss in nasopharyngeal carcinoma using the three methods of regulating spleen function, clearing heat, and nourishing yin [J]. Jiangsu Journal of Traditional Chinese Medicine, 2011,43(7):2.
  56. Zhou Qin. Clinical observation of modified Shengmai Powder combined with nintuzumab in patients with stage III/IV EGFR-positive nasopharyngeal carcinoma of the qi-yin deficiency type treated with radiotherapy [D], 2023.
  57. She Wenyi, Tian Daofa, Wang Xianwen. Summary of Professor Tian Daofa's clinical experience in treating nasopharyngeal carcinoma based on the theory of "qi deficiency and toxin accumulation" [J]. China Journal of Integrated Traditional Chinese and Western Medicine in Otorhinolaryngology, 2023,31(01):69-74.
  58. Lin Ting, Dai Na, Luo Jingjing, et al. Study on the induction of autophagy in nasopharyngeal carcinoma cells by Yiqi Jiedu Formula through the PI3K/AKT/mTOR signaling pathway [J]. Chinese Journal of Traditional Chinese Medicine, 2020,35(03):1484–1488.
  59. Fan Jingying, Liu Jie, Liu Xiaodan, et al. The effect of Yiqi Jiedu Formula on the proliferation of nasopharyngeal carcinoma CNE2 cells via the Wnt/β-catenin signaling pathway [J]. Journal of Hunan University of Chinese Medicine, 2020,40(05):535–59.
  60. He Lan, Zhou Fangliang, Zou Pan, et al. Yiqi Jiedu Formula combined with salinomycin regulates proliferation, migration, and apoptosis of nasopharyngeal carcinoma stem cells through the CD44/Ras signaling pathway [J]. Journal of Digital Traditional Chinese Medicine, 2020,3(04):297–308. DOI: https://doi.org/10.1016/j.dcmed.2020.12.008.
  61. Zou Pan, Cheng Bo, Zhong Wenliang, et al. Molecular mechanisms of Yiqi Jiedu Formula in treating nasopharyngeal carcinoma based on network pharmacology and bioinformatics studies [J]. Chinese Patent Medicines, 2022,44(06):2021-7.